Position in XENE
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$4,965,312
+$1,695,380 QoQ
Shares Held
85,388
+17.0% QoQ
Ownership
0.088%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Y-Intercept (Hong Kong) Ltd holds $167,724,147 across 89 Biotechnology names. XENE ranks #5 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
35,829 | $15,999,081 | |
| 2 | ADMA |
Adma Biologics, Inc.
|
1,075,422 | $9,689,552 | |
| 3 | UPB |
Upstream Bio, Inc.
|
1,000,631 | $9,005,679 | |
| 4 | ANNX |
Annexon, Inc.
|
1,319,913 | $7,312,318 | |
| 5 | XENE |
Xenon Pharmaceuticals Inc.
This page
|
85,388 | $4,965,312 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
218,354 | $4,574,516 | |
| 7 | INCY |
Incyte Corp
|
47,833 | $4,502,041 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
78,338 | $4,425,313 |
All Filings in XENE
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,965,312 | 85,388 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $3,269,932 | 72,957 | Shares | Sole | 2026-02-13 | |
| 2025-03-31 | $400,888 | 11,949 | Shares | Sole | 2025-05-06 | |
| 2024-09-30 | $966,809 | 24,557 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $567,304 | 14,550 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $788,030 | 18,305 | Shares | Sole | 2024-05-10 | |
| 2022-06-30 | $222,796 | 7,324 | Shares | Sole | 2022-08-08 | |
| No filing history on record for this holder in this stock. | ||||||